Skip to content

UNIGENE LABORATORIES INC: 10-Q/A filed 2013-01-31

What UNIGENE LABORATORIES INC reported in its quarterly report amendment filed 2013-01-31 (fiscal Q2 2012): 39 published measures, 104 facts as tagged in accession 0001437749-13-000966.

This is an amendment. Values here are as tagged in the amendment; the original filing has its own page.

This filing

Form
10-Q/A (quarterly report amendment)
Filed
2013-01-31
Fiscal period
fiscal Q2 2012
Accession
0001437749-13-000966 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; a measure with a published history links to it, and the history shows the latest-filed value per period. All UNIGENE LABORATORIES INC filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2012-06-3012,032,499USD
At 2011-12-3118,195,169USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2012-06-3091,422,755USD
At 2011-12-3183,892,333USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2012-06-30-79,390,256USD
At 2011-12-31-65,697,164USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2012-06-301,749,608USD
At 2011-12-314,681,683USD
At 2011-06-309,118,503USD
At 2010-12-3112,200,800USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2012-04-01 to 2012-06-30-11,245,967USD91
2012-01-01 to 2012-06-30-14,442,616USD182
2011-04-01 to 2011-06-302,342,484USD91
2011-01-01 to 2011-06-30-30,445,148USD181

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2012-01-01 to 2012-06-30-1,718,648USD182
2011-01-01 to 2011-06-30-2,306,195USD181

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2012-01-01 to 2012-06-30140,120USD182
2011-01-01 to 2011-06-30255,049USD181

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2012-04-01 to 2012-06-302,737,532USD91
2012-01-01 to 2012-06-304,488,815USD182
2011-04-01 to 2011-06-302,469,052USD91
2011-01-01 to 2011-06-304,594,861USD181

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2012-01-01 to 2012-06-30-322,259USD182
2011-01-01 to 2011-06-3053,521USD181

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2012-01-01 to 2012-06-30-891,168USD182
2011-01-01 to 2011-06-30-829,623USD181

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2012-06-30-196,783,894USD
At 2011-12-31-182,341,278USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2012-04-01 to 2012-06-3095,361,740shares91
2012-01-01 to 2012-06-3095,338,282shares182
2011-04-01 to 2011-06-3092,534,316shares91
2011-01-01 to 2011-06-3092,497,652shares181

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2012-04-01 to 2012-06-3095,361,740shares91
2012-01-01 to 2012-06-3095,338,282shares182
2011-04-01 to 2011-06-3095,176,397shares91
2011-01-01 to 2011-06-3092,497,652shares181

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2012-04-01 to 2012-06-30-0.12USD/shares91
2012-01-01 to 2012-06-30-0.15USD/shares182
2011-04-01 to 2011-06-300.03USD/shares91
2011-01-01 to 2011-06-30-0.33USD/shares181

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2012-04-01 to 2012-06-30-0.12USD/shares91
2012-01-01 to 2012-06-30-0.15USD/shares182
2011-04-01 to 2011-06-300.02USD/shares91
2011-01-01 to 2011-06-30-0.33USD/shares181

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2012-01-01 to 2012-06-30-26,758USD182

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2012-06-302,942,155USD
At 2011-12-312,977,058USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2012-01-01 to 2012-06-30736,414USD182
2011-04-01 to 2011-06-307,000USD91
2011-01-01 to 2011-06-30922,686USD181

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2012-04-01 to 2012-06-30-1,936,796USD91
2012-01-01 to 2012-06-30-4,643,063USD182
2011-04-01 to 2011-06-30-3,070,102USD91
2011-01-01 to 2011-06-30-6,704,034USD181

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2012-06-305,031,837USD
At 2011-12-3110,290,225USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2012-04-01 to 2012-06-303,281,755USD91
2012-01-01 to 2012-06-306,148,758USD182
2011-04-01 to 2011-06-302,689,702USD91
2011-01-01 to 2011-06-305,128,242USD181

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2012-06-3084,713,792USD
At 2011-12-315,696,756USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2012-06-301,047,712USD
At 2011-12-311,472,925USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

PeriodValueUnitDays
At 2012-06-302,014,176USD
At 2011-12-312,020,458USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2012-06-301,068,152USD
At 2011-12-312,854,038USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2012-04-01 to 2012-06-304,674,328USD91
2012-01-01 to 2012-06-309,131,878USD182
2011-04-01 to 2011-06-305,539,154USD91
2011-01-01 to 2011-06-3011,298,895USD181

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2012-06-301,209,641USD
At 2011-12-311,283,550USD

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

PeriodValueUnitDays
2012-04-01 to 2012-06-302,164,596USD91
2012-01-01 to 2012-06-304,258,016USD182
2011-04-01 to 2011-06-302,321,237USD91
2011-01-01 to 2011-06-304,644,895USD181

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2012-04-01 to 2012-06-301,379,374USD91
2012-01-01 to 2012-06-302,638,033USD182
2011-04-01 to 2011-06-302,098,159USD91
2011-01-01 to 2011-06-304,519,287USD181

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2012-06-30116,439,489USD
At 2011-12-31115,691,958USD

Long-term debt

Long-term borrowings under this concept, which can include the current portion depending on presentation. It is not total liabilities and may exclude leases and other obligations.

PeriodValueUnitDays
At 2012-06-3054,898,739USD
At 2011-12-3147,420,974USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

PeriodValueUnitDays
At 2012-06-302,014,176USD
At 2011-12-312,020,458USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2012-06-30415,049USD
At 2011-12-31960,781USD

Other noncurrent liabilities

Noncurrent liabilities the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2012-06-305,575,920USD
At 2011-12-316,101,287USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2012-06-301,004,436USD
At 2011-12-31862,761USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2012-04-01 to 2012-06-30-11,245,967USD91
2012-01-01 to 2012-06-30-14,469,374USD182
2011-04-01 to 2011-06-302,342,484USD91
2011-01-01 to 2011-06-30-30,445,148USD181

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2012-01-01 to 2012-06-30401,555USD182
2011-01-01 to 2011-06-30348,212USD181

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

PeriodValueUnitDays
2012-01-01 to 2012-06-3055,000USD182
2011-01-01 to 2011-06-3048,000USD181

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2012-01-01 to 2012-06-30-391,274USD182
2011-01-01 to 2011-06-30-58,082USD181

Inspect the source

Entity
UNIGENE LABORATORIES INC / CIK 0000352747
Captured
SEC response SHA-256
b5f82fa201083b12be312039e3ed1f63c9fd8fc7c8ed9d7ce87dfd8eeb9db641

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000352747.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))